Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Macha Tetart

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Antimicrobial Chemotherapy|January 14, 2022
Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infectionsPauline Thill, Olivier Robineau, Gabrielle Roosen, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2023
Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in FranceMacha Tetart, Priscila Passecountrin, Anaïs Lesourd, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2025
Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutationsEnagnon Kazali Alidjinou, Pauline Coulon, Macha Tetart, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Antimicrobial Chemotherapy|January 14, 2022
Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infectionsPauline Thill, Olivier Robineau, Gabrielle Roosen, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2023
Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in FranceMacha Tetart, Priscila Passecountrin, Anaïs Lesourd, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2025
Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutationsEnagnon Kazali Alidjinou, Pauline Coulon, Macha Tetart, et al.
Pageof 2